new colon cancer treatments 2

New Colon Cancer Treatments have the Potential to Halt the Disease by Turning On a Protein ‘Like a Light Switch’

Is an Australian study paving the way for some new colon cancer treatments?

If a new study is to be believed then researchers are very well on their way to developing a medical breakthrough for colon cancer prevention.

Scientists at the Australian National University have discovered a way to use medication to turn on a protein that blocks cancer and may remove damaged DNA from the body “like a light switch,” as reported by the New York Post.

SIMILAR: Read about a teen innovator from India who’s developing a new gadget for dementia care.

The protein known as Ku70, as per researcher Dr. Abhimanu Pandey, “In its activated state, the protein acts like a surveillance system, detecting signs of damaged DNA in our cells.”

“Damaged DNA,” he continued, is usually an early warning indicator that cells may develop into cancer. Ku70 has the power to undo or at least slow down the harm.

According to the research, Ku70 can both clean up damaged DNA and “cool down” cancer cells. The protein essentially deactivates and confines the cancer cells in a latent state by preventing them from being more aggressive and from spreading throughout the body. 

In 2020, the Centers for Disease Control and Prevention received reports and showed horrifying statistics of 126,240 cases of colorectal cancer in the United States. 51,869 people lost their lives to the deadly disease that year.

new colon cancer treatments
Stock image of colon

In Australia, the study’s location, it was found that 100 persons pass away from some sort of bowel cancer every week.

However, the research, which is now published in Science Advances, indicates that 90% of cases may be successfully treated if discovered early on and this could prove to be a new treatment for colon cancer.

It is well known that prompt identification and intervention are essential for conquering not just colorectal cancer but also other cancers, according to researcher Si Ming Man Man. 

Man went on to say that measuring for Ku70 levels may soon be part of the screening process for malignancies like colon cancer.

He clarified, “Our findings indicate that Ku70 is a useful immune biomarker, which aids in the prediction of patients’ prognosis following a diagnosis of bowel cancer.” 

Maya Bennett